We conducted a randomized, controlled, double-blind, prospective study to evaluate the effect of intraoperative bupivacaine injection on postoperative pain control fol-lowingBovie cautery-assisted tonsillectomy in 26 adults. Sixteen patients were injected with 10 ml of 0.5% bupivacaine with 1:200,000epinephrine, and 10 were injected with 10 ml of normal saline solution. For 10 days after surgery, patients completed a questionnaire to rate their overall pain and to record their narcotic consumption and oralintake. At study's end, there was no statistically significant difference in pain scores, narcotic use, and oral intake between the bupivacaine group and the controls (p = 0.13,0.37, and 0.35, respectively). We conclude that the effects ofperioperative bupivacaine on postoperative pain control in tonsillectomy patients aresimilarto those ofplacebo.
Introduction
Postoperative pain is the primary morbidity associated with tonsillectomy. Various surgical and pharmacologic strategies have been undertaken in an effort to reduce post -tonsillectomy pain. Surgical advancements have included the introduction of harmonic scalpel tonsillectomy, potassium-titanyl-phosphate (KTP) laser ablation, and subcapsular dissection with the debrider. Pharmacologic strategies have included the peri operative administration of steroids, antibiotics, and anesthetics.
The influence of local anesthesia on the course of post-tonsillectomy pain is ambiguous. Ginstrorn et al reported that while intraoperative infiltration of bupivacaine/ epinephrine resulted in a significant decrease in intraoperative blood loss, it had only a marginal effect on pain; what effect it did have was principally seen in the postoperative anesthesia care unit. ' In a pediatric population, Naja et al found that a preincision injection of local anesthesia resulted in significantly less postoperative pain at rest, on jaw opening, and during intake of a soft diet compared with findings in a placebo group and a general anesthesia group. ' Previously published data by our group indicated that patients who underwent local infiltration of bupivacaine into the tonsillar fossa immediately following tonsillectomy did not have less pain than did placebo controls. ' We conducted the present randomized, controlled, double-blind, prospective study to test our earlier findings and to perhaps determine if there is a role for local anesthesia in reducing post-tonsillectomy pain .
Patients and methods
Study population. Our study population consisted of 26 patients-6 men and 20 women (mean age: 24.5 ± 5.8 yr)-who had undergone tonsillectomy for either chronic ton sillitis or tonsillar hypertrophy. The number of infections per year ranged from 3 to 7.
Surgical technique. All patients underwent Bovie cautery-assisted tonsillectomy after induction of general anesthesia. Anesthesia was standardized for all patients; induction of propofol was followed by nitrous oxide and isoflurane for maintenance. Intraoperative pain management consisted of intravenous fentanyl 2 flg/kg, and paralysiswasmanaged with intravenous mivacurium 0. 6, the trend was no t statistically significant, an d there was no overall difference between the 2 gro ups (p = 0.37). The trends in both groups paralleled the respective declines in pain scores .
Oral intake. The mean daily total oral intake was plotted over time (figur e 3). Although there was a tre nd toward greater intake in the bupivacaine gro up, the overall difference did no t reach statistical significance (p = 0.35).
Discussion
As me ntio ned, several surgica l and medical stra tegies have been undertaken in an effort to reduce posttonsill ectomy pain:
Su rgical technique. A series of recently published report s have suggested th at surgica l technique may Following com pletion of th e act ua l ton sillectomy portion of the operation, patients received a 10-ml injection of either 0.5% bupivacaine wit h 1:200,000 epine phr ine (n = 16) or normal saline solu tion (n = 10). Patie nts had been rando mized pri or to surgery, and th e surgeon was blinded to the type of injection. Injections were m ade in a serial fashion to include th e base of the uvula and th e ante rio r and posteri or ton sillar fossae, and care was taken to avoid intravascular Figure1. Meanpain scores in the2 groups were not significantly differentovertime (p = 0.13).
injection.Then th estomach contents were aspirated, and patients were awakened from anest hesia and extubated.
Postoperative care. In the postanesthesia care uni t, patients were given morphine as needed for pain and ondansetron as needed for nausea and vomiting. Discharge medications included amoxicilli n or a first-generation cephalosporin for 10 days and either acetaminophen/ codei ne 120/12 mg per 5 ml for pain or another narcotic preparation if acetaminophen/co deine was not tolerated.
Self-assessments.For 10 days postoperatively,pat ients were asked to rate th eir pain on a scale of 0 (no ne) to 10 (severe). They were also asked to recor d th e amo unt of narcotic pain medication they required and the amo unt of ora l intake th ey were able to achieve.
Statistical analysis.Th e data were analyzed according to th e Student t test, and a p value of <0.05 was cons idered to be statistically significant.
App roval. Th is study was approved by the UVA Institution al Review Board. m40 T ---------------~£~"1F =~1 Figure 2 . No signifiCil nt difference was seen in the mean amount of narcoticanalgesics usedby the 2 groups (p = 0.37).
Results
Pain. The mean pain scores in the treatment group and the control group were plotted over time (figure 1). Overall, there was no significant difference between the 2 gro ups (p = 0.13) . The pain in the bupivacaine group did not begin to subside un til postoperative day 5. However you define success, Eyemaginations ENT program will help you achieve it. It delivers your message in more places at once...from the waiting room to the exam lanes to the hearing aid fitting area. It enables you to educate, explain conditions and offer solutions, clearly and persuasively. It helps you to provide better care to more patients. And that helps build a more profitable practice ...because better informed patients make the best decisions. Call for a demo. Introduced one year ago, the Eyemaginations Office -ENT software system for otolaryngology professionals helps build a more successful practice by delivering the doctor's message throughout the entire practice from waiting room to the exam rooms to the audiology rooms. It helps streamline and enhance the patient consultation process by explaining conditions and offering solutions, clearly and concisely.
With Office -ENT, doctors can provide the ultimate experience through dynamic animations on relevant medical topics and treatment options. Patients will see, learn and better comprehend options before making the ir decisions.
Exam Advisor -allows a doctor to use an interactive feature to show the progression of conditions and pathologies so that patients can understand what can happen if the condition becomes more severe. The draw-over-video technology gives the doctor greater flexibility to further customize the presentation to the patient.
Scheduler -enables the practice to turn the waiting room into a revenue driver by delivering custom ized presentations that focus idle patients on the most profitable products and procedures . The doctor's staff can even slot specific topics into a weekly calendar to ta rget certain groups of pat ients . Office -ENTdoes the selling so you don't have to.
Media Center -allows you to store animations, still im-ages and even your own content to access when making a playlist. Don't have time to build your own playlists? No problem, with the Quick List feature, all the work has been done for you. Choose from pre-compiled lists covering a range of topics .
If you're ready to make your practice more successful, visit ent.eyemagintions.com for more information and to view a short video or you can call 877.321.5481. have an imp act on po st-tonsillectomy pain outcomes. Lister et al found that pediatric pati ents who underwent microdebrider intracapsular tonsillotomy on one ton sil and electrocautery extracapsular tonsillectomy on the other reported significantly less pain on the microdebrider side on postoperative days 1through 9. 4 However, Sobol et al observed no difference in postoperative pain between,children who underwent microdebrider intracapsular tonsillotomyor monopolar electrocautery tonsi llectomy; also, there was no significant differenc e in th e tota l number of days before pati ents returned to normal activity, although there was a significant differenc e in favor of microdebrider tonsillectomy in the return to a normal diet. "
Polites et al found that adults who underwent Cob lation-assisted tonsill ectomy reported significantly less pain on postop erative days 1 and 3 than did thos e who underwent dissection tonsillectomy; there was no significant difference in tot al recovery time ." Finally, Glade et al reported a lower incidence of neck pain (and dehydration) in children who underwent Coblation techniques as opposed to electrocautery. ' Overall, the data seem to suggest that surgic al technique may offer some benefit in the early reduction of pain following tonsillectomy.
Steroid injections. Oh lms et al conducted a randomized, double-blind, placebo -controlled clinical trial of a single intravenous dose of dexam etha sone in children and found no significant differences in postoperative pain between the tr eated pat ient s and th e controls."Nor did they find any differences in nausea, eme sis, halitosis, th e need for analgesic medication s, th e type of diet, and activity levels.
Conversely, Afman et al recently reported a metaanalysis of eight r andomized, controlled, double-blind studies of a single intraoperative dose of corticosteroid in children and found that there was a significant reduction in pain 2 to 7 hours postoperatively in those patients who had been administered between 0.4 and 1.0 mg/kg of dexamethasone." Antibiotic injections. Dat a from a sevenstudy meta-analysis conducted by Burkart and Steward dem onstrated that both adult and ped iatric patients who had been treated return to a normal diet and normal activity, but th ey found no significant difference in postoperative pain scores .'? A similar lack of efficacy with regard to pain was found in a meta-analysis of five tri als ofintra-and/or postoperative antibiotics repor ted by Dhiwakar et al.11
On the other hand, a single-day regimen of a topica l antibiotic was shown by Mann et al to be more effective th an placebo in reducing postoperative pain in adult s." Anesthetic injections. As mentioned, the influence of local anesthetic injections on reducing post-tonsillectom y pain is equivocal. The timin g of injections (i.e., preincision or postoperative) do es not appear to have any effect on self-rated pain scores. In our study, the lack of bupivacaine effect seen subjectively was confirmed by objective data-that is, the amount s of narcotic con sumption and daily oral intake. The findings of the present study also confirm those of our earlier stud y.' However, th e difficulti es of assessing subje ctive dat a such as pain scores are well known, and the use of a visual analog scale may be a more appropriat e assessment tool. 13 Th e half-life of bupivacaine is 2.7 hours in adults. Systemic absorption of bupivacaine is dependent on the tot al doseand concentration administered, the route of administration, vascular ity at the administration site, and the use of epinephrine. Epinephrine used at a concentration of 1:200,000 usually reduces the rate of absorption and the peak plasma concentration of bupivacaine, thus allowing for larger total dos es, which may prolong its duration of action.
With respect to the pharmacokinetic properties of bupivacaine, both the time it takes to achieve its maximum analgesic effect and the specific route of administration warr ant further study. In the p resent study, we did not examine the effect of bupivacaine during the immediate postoperative period (i.e., within hours of administration), and thus we do not know if its use had any significant impact on the amo un t of time patients spent in the recovery suite. Moreo ver, subcuta neo us delivery of microencapsulated bup ivacaine has been show n to extend its analgesic effect for as lon g as 96 hour s witho ut delaying its onset of action."
Althou gh our data suggest tha t intraoperative bu pivacaine injection does not significantly reduc e postopera tive pain, the hypoth esis that local anesthetics in general may do so sho uld not be abando ned as newer preparations with more sustained analgesic effects become available.
